A detailed history of Empirical Finance, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 3,948 shares of DGX stock, worth $541,231. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,948
Previous 3,872 1.96%
Holding current value
$541,231
Previous $529,000 2.27%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$137.09 - $137.09 $10,418 - $10,418
76 Added 1.96%
3,948 $541,000
Q2 2024

Jul 30, 2024

SELL
$125.91 - $144.34 $43,816 - $50,230
-348 Reduced 8.25%
3,872 $529,000
Q1 2024

May 06, 2024

BUY
$123.78 - $142.11 $17,205 - $19,753
139 Added 3.41%
4,220 $561,000
Q3 2023

Nov 02, 2023

BUY
$121.86 - $144.92 $37,289 - $44,345
306 Added 8.11%
4,081 $497,000
Q2 2023

Jul 27, 2023

BUY
$130.56 - $146.84 $44,782 - $50,366
343 Added 9.99%
3,775 $530,000
Q1 2023

Apr 05, 2023

BUY
$131.53 - $155.76 $19,203 - $22,740
146 Added 4.44%
3,432 $485,000
Q4 2022

Jan 24, 2023

BUY
$123.31 - $157.26 $27,374 - $34,911
222 Added 7.25%
3,286 $514,000
Q3 2022

Nov 04, 2022

SELL
$121.77 - $141.1 $344,000 - $398,607
-2,825 Reduced 47.97%
3,064 $376,000
Q2 2022

Aug 01, 2022

SELL
$127.07 - $145.39 $464,822 - $531,836
-3,658 Reduced 38.32%
5,889 $783,000
Q1 2022

Apr 21, 2022

BUY
$129.09 - $164.35 $31,627 - $40,265
245 Added 2.63%
9,547 $1.31 Million
Q4 2021

Feb 04, 2022

SELL
$140.36 - $173.01 $529,859 - $653,112
-3,775 Reduced 28.87%
9,302 $1.61 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $581,922 - $691,566
4,377 Added 50.31%
13,077 $1.9 Million
Q2 2021

Aug 10, 2021

BUY
$126.66 - $141.48 $1.1 Million - $1.23 Million
8,700 New
8,700 $1.15 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.